ARTICLE | Company News
Management tracks: Editas, Allina Health | Aetna
March 28, 2018 10:09 PM UTC
Genome editing company Editas Medicine Inc. (NASDAQ:EDIT) named James Mullen chairman of the board of directors. He was CEO of Patheon N.V., which Thermo Fisher Scientific Inc. (NYSE:TMO) acquired...